Articles tagged with Bioterrorism
The University of Louisville has been designated as a CDC biodefense center, equipped with resources and expertise to research and prepare for bioterrorism attacks. The center will conduct epidemiological and communications research to ensure quick responses to potential epidemics.
The U-M Bioterrorism Preparedness Initiative has received a $1 million grant from the Centers for Disease Control and Prevention to develop web-based training for over 9,000 public health workers in Michigan. The initiative aims to improve the state's public health system's ability to prevent and respond to infectious disease outbreaks.
The HHS has awarded contracts to Avecia and VaxGen Inc. to develop a new anthrax vaccine that can provide immunity in three or fewer doses, reducing administration time. The vaccine will be produced using recombinant DNA technology and is expected to protect individuals from anthrax spores even if administered shortly after exposure.
The consortium will analyze patient records to identify clusters of health complaints associated with bioterror agents. The system aims to detect unusual increases in people contacting help lines or primary care doctors, enabling a rapid response to public health officials.
Mayo Clinic researchers have discovered a way to use autoclave sterilization procedures in laboratory settings to detect and confirm the identity of smallpox virus and other bioterrorism agents. This innovation enables local laboratories to conduct rapid tests, reducing the time needed to respond to potential attacks.
Chemical engineers have developed a novel process to grow crops of nanowires, which could lead to improved design of advanced military and space gear, fuel cells, sensors and solar devices. The process uses pools or thin films of low-melting metals like gallium to create the nanowires.
The Texas A&M University Institute for Countermeasures against Agricultural Bioterrorism aims to develop research tools to prevent and respond to terrorist attacks on agriculture. The institute will utilize cutting-edge technologies such as surveillance networking, satellite imaging, and biotechnology to create a proactive defense system.
Researchers at UMass are working on sensors that can identify bioterror agents more accurately by connecting small 'keys' to large molecules. The team is using nanoparticles and gold structures to solve the complex problem of detecting larger molecules, which have a difficult time fitting into traditional chemical sensors.
Measles researchers used statistical techniques to pinpoint epidemic patterns in cities, revealing a two-year cycle, with larger cities catching on faster. The disease spreads through waves at about 5 kilometers per week, primarily carried by school children.
The US government is investing in bioterrorism research through seven new initiatives, aiming to develop vaccines and treatments for diseases like anthrax and smallpox. The initiatives will also support basic research and partnerships between academia, industry, and government.
A Johns Hopkins study suggests that the public can effectively respond to bioterrorism attacks without panic. The researchers recommend providing timely accurate information and creating a constructive role for the public, who can adapt to situations based on available information.
A scholar warns that excessive information-seeking can exacerbate mental health concerns, particularly in times of high uncertainty. Brashers advises people to balance their desire for information with the need to avoid extreme anxiety, suggesting they listen to trusted sources and verify information through reputable agencies.
The US Department of Defense has awarded the University of South Florida $4 million to develop a statewide public health system capable of responding to bioterrorism threats. The project aims to create a surveillance system that can detect and track both naturally occurring infectious diseases and potential bioterrorist attacks.
The Biomedical Security Institute will provide a nationwide preparedness, detection and response capability network for rapid response to acts of bioterrorism. It will also monitor naturally occurring biological catastrophes and develop laboratory and information technologies to address bioterrorism issues.
A Saint Louis University School of Medicine Center for Vaccine Development study will focus on the effectiveness of diluted doses of Dryvax, a smallpox vaccine. The goal is to increase the available stock by up to 100 fold, which could improve the nation's ability to protect citizens in the event of a bioterrorism attack.
Bioterrorism poses a significant threat to US agriculture, with pathogens like soybean rust capable of devastating yields and contaminating the food supply. Experts are working to identify the most-threatening pathogens and develop strategies for prevention and response.